EGFR and non-small cell lung carcinoma: On the other hand, Gao et al. analyzed clinical outcomes of coexisting T790M in a surgically resected, EGFR-mutated NSCLC cohort using the Amplification Refractory Mutation System, of which the analytical sensitivity was known to be generally 1% [37].